Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcium levulinate is a relatively new, highly bioavailable organic salt of calcium derived from the reaction of levulinic acid and calcium hydroxide. It is used as a pharmaceutical preparation for treating acute or chronic hypocalcemia and other conditions requiring rapid elevation of serum calcium levels. The compound features high solubility (over 30% at 25°C), neutral pH, and low irritation potential, making it suitable for oral, parenteral (injection/infusion), and food fortification applications. Calcium levulinate provides approximately 14.8% more elemental calcium than commonly used alternatives like calcium lactate. Its mechanism involves dissociation in the gastrointestinal tract or bloodstream to release free Ca2+ ions, which are then absorbed to replenish body stores[1][2][5][6][7]. Calcium levulinate is also widely used as a food fortifier in beverages, dairy products, soy products, sauces, and other foods due to its high solubility and stability[1][2][3][4]. It is considered non-toxic and non-allergenic with good taste profile[5]. No specific brand names were identified; it is generally marketed under its generic name.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium levulinate.